Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2012; 18(7): 654-661
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.654
Figure 2
Figure 2 SKLB010 reduces the production of inflammatory mediators in vivo. A: Blood was collected at different time points (5 rats per time point). Tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were assayed in serum using an enzyme linked immunosorbent assay (mean ± SD). Nitric oxide (NO) was assayed in serum using a NO assay kit aP < 0.05, bP < 0.01 vs the level of carbon tetrachloride (CCl4) administration at each time point; B: Total RNA was prepared at different time points for the reverse transcription-polymerase chain reaction (RT-PCR) analysis of TNF-α, IL-1β and iNOS gene expression. IL-1β-specific sequences (387 bp), TNF-α-specific sequences (351 bp) and inducible nitric oxide synthase (iNOS)-specific sequences (474 bp) were detected by agarose gel electrophoresis, as described in Methods. PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed to verify that the contents of the samples were similar.